Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Retained Earnings (2016 - 2026)

Celcuity's (CELC) quarterly Retained Earnings came in at -$448.9 million in Q4 2025, down 65.12% YoY from -$1.3 billion in Q4 2024, and down 12.81% on a QoQ basis from -$397.9 million in Q3 2025.

Analysis

Celcuity (CELC) Retained Earnings (2016 - 2026) Analysis & Trends

Celcuity (CELC) has 10 years of Retained Earnings data on file, last reported at -$448.9 million in Q4 2025.

  • Quarterly Retained Earnings fell 65.12% year-over-year to -$448.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$448.9 million (down 65.12% YoY) and the FY2025 annual result came in at -$448.9 million, down 65.12% from the prior year.
  • Retained Earnings eased to -$448.9 million in Q4 2025, from -$397.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $398.5 million in Q2 2025 to a low of -$448.9 million in Q4 2025.
  • A 5-year average of -$57.6 million and a median of -$79.3 million in 2022 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2021 — Retained Earnings tumbled 231.05% — and 2022, when it surged 511.33%.
  • Tracing CELC's Retained Earnings over 5 years: stood at -$55.9 million in 2021, then surged by 511.33% to $230.0 million in 2022, then plunged by 169.58% to -$160.1 million in 2023, then slumped by 69.83% to -$271.9 million in 2024, then tumbled by 65.12% to -$448.9 million in 2025.
  • The last three Retained Earnings figures came in at -$448.9 million (Q4 2025), -$397.9 million (Q3 2025), and $398.5 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Celcuity 5.25 Bn 5.25 Bn - -580.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -580.60 Mn
Dec 31, 2025 549.40 Mn
Sep 30, 2025 514.84 Mn
Jun 30, 2025 398.46 Mn
Mar 31, 2025 395.48 Mn
Dec 31, 2024 387.44 Mn
Sep 30, 2024 384.87 Mn
Jun 30, 2024 382.06 Mn
Mar 31, 2024 315.39 Mn
Dec 31, 2023 299.82 Mn
Sep 30, 2023 234.10 Mn
Jun 30, 2023 232.93 Mn
Mar 31, 2023 231.44 Mn
Dec 31, 2022 230.05 Mn
Sep 30, 2022 128.23 Mn
Jun 30, 2022 127.00 Mn
Mar 31, 2022 125.39 Mn
Dec 31, 2021 124.62 Mn
Sep 30, 2021 123.63 Mn
Jun 30, 2021 70.17 Mn